A pathogenic role for secretory IgA in IgA nephropathy

Kidney International

Volumn 69, Issue 7, 2006, Pages 1131-1138

  Oortwijn, B D ^a   Van Der Boog, P J M ^a   Roos, A ^a   Van Der Geest, R N ^a   De Fijter, J W ^a   Daha, M R ^a   Van Kooten, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human; IgA nephropathy; Mannose receptor; Mesangial cells; Polymeric IgA; Secretory IgA

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COMPLEMENTARY DNA; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLOMERULUS; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; MALE; MESANGIUM CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; MOLECULAR WEIGHT;

EID: 33645515736     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000074     Document Type: Article

References (57)

1. Berger J, Hinglais N. Les depots intercapillaires d'IgA-IgG. J Urol Nephrol (Paris) 1968; 74: 694-695.
2. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748.
3. Feehally J. IgA nephropathy - a disorder of IgA production? Q J Med 1997; 90: 387-390.
4. Tomino Y, Sakai H, Miura M et al. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 1982; 49: 419-425.
5. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004; 24: 197-217.
6. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11: 2395-2403.
7. Novak J, Julian BA, Tomana M et al. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 2001; 21: 310-327.
8. van der Boog PJ, van Kooten C, de Fijter JW et al. Role of macromolecular IgA in IgA nephropathy. Kidney Int 2005; 67: 813-821.
9. van der Boog PJ, van Zandbergen G, de Fijter JW et al. Fc alpha RI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. J Immunol 2002; 168: 1252-1258.
10. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973.
11. Allen AC, Bailey EM, Barratt J et al. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999; 10: 1763-1771.
12. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509-516.
13. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC et al. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28: 666-671.
14. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085.
15. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE et al. Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 1994; 46: 512-519.
16. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E et al. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994; 153: 5247-5255.
17. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997; 159: 3474-3482.
18. Lai KN, Tang SC, Guh JY et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 2003; 14: 3127-3137.
19. Kerr MA. The structure and function of human IgA. Biochem J 1990; 271: 285-296.
20. Johansen FE, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001; 167: 5185-5192.
21. Thompson RA, Asquith P, Cooke WT. Secretory IgA in the serum. Lancet 1969; 2: 517-519.
22. Delacroix DL, Vaerman JP. A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum. J Immunol Methods 1981; 40: 345-358.
23. Mole CM, Renoult E, Bene MC et al. Serum secretory IgA and IgM and free secretory component in IgA nephropathy. Nephron 1995; 71: 75-78.
24. Seilles E, Rossel M, Vuitton DA et al. Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases. J Hepatol 1995; 22: 278-285.
25. Rostoker G, Terzidis H, Petit-Phar M et al. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. Clin Exp Immunol 1992; 90: 305-311.
26. Norderhaug IN, Johansen FE, Schjerven H et al. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 1999; 19: 481-508.
27. Hughes GJ, Reason AJ, Savoy L et al. Carbohydrate moieties in human secretory component. Biochim Biophys Acta 1999; 1434: 86-93.
28. Barratt J, Greer MR, Pawluczyk IZ et al. Identification of a novel Fcalpha receptor expressed by human mesangial cells. Kidney Int 2000; 57: 1936-1948.
29. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004; 15: 622-634.
30. Woodard CS, Splawski JB, Goldblum RM et al. Characterization of epitopes of human secretory component on free secretory component, secretory IgA, and membrane-associated secretory component. J Immunol 1984; 133: 2116-2125.
31. Heystek HC, Moulon C, Woltman AM et al. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J Immunol 2002; 168: 102-107.
32. van Spriel AB, Leusen JH, Vile H et al. Mac-1 (CD11b/CD18) as Accessory molecule for FcalphaR (CD89) binding of IgA. J Immunol 2002; 169: 3831-3836.
33. Silva FG, Chander P, Pirani CL et al. Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 1982; 33: 241-246.
34. Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 1982; 33: 370-376.
35. 4 receptor is critical for implantation in vivo. J Clin Invest 2002; 109: 269-276.
36. Egido J, Sancho J, Mampaso F et al. A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schonlein-Henoch syndrome. Proc Eur Dial Transplant Assoc 1980; 17: 660-666.
37. Komatsu N, Nagura H, Watanabe K et al. Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy. Nephron 1983; 33: 61-64.
38. Valentijn RM, Radl J, Haaijman JJ et al. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 1984; 26: 760-766.
39. Amore A, Cirina P, Conti G et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862-1871.
40. Amore A, Conti G, Cirina P et al. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 2000; 36: 1242-1252.
41. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513.
42. Royle L, Roos A, Harvey DJ et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem 2003; 278: 20140-20153.
43. Leung JC, Tsang AW, Chan DT et al. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 2000; 11: 241-249.
44. Westerhuis R, van Zandbergen G, Verhagen NA et al. Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). J Am Soc Nephrol 1999; 10: 770-778.
45. van Egmond M, van Garderen E, van Spriel AB et al. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000; 6: 680-685.
46. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 1994; 12: 63-84.
47. Russell MW, Lue C, van den Wall Bake AW et al. Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol 1992; 87: 1-6.
48. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-961.
49. van der Boog PJ, van Kooten C, van Seggelen A et al. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant 2004; 19: 2487-2493.
50. de Fijter JW, van den Wall Bake AW, Braam CA et al. Immunoglobulin A subclass measurement in serum and saliva: sensitivity of detection of dimeric IgA2 in ELISA depends on the antibody used. J Immunol Methods 1995; 187: 221-232.
51. Woltman AM, de Fijter JW, Kamerling SW et al. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30: 1807-1812.
52. Hiemstra PS, Baldwin WM, van der Voort EA et al. Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients. Transplantation 1988; 45: 701-705.
53. van Kooten C, Gerritsma JS, Paape ME et al. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997; 51: 711-721.
54. Nauta AJ, De Haij S, Bottazzi B et al. Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 2005; 67: 543-553.
55. de Heer E, Daha MR, Van Es LA. Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen. Immunology 1984; 52: 743-752.
56. Mestecky J, Hamilton RG, Magnusson CG et al. Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study. J Immunol Methods 1996; 193: 103-148.
57. de Fijter JW, van Nisselrooij NI, Schroeijers WE et al. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy. Nephrol Dial Transplant 1998; 13: 285-292.